Skip to main content
Study: ADT doesn't raise dementia risk in vets with prostate cancer

Researchers at the University of California at San Diego School of Medicine found that androgen deprivation therapy, regardless of duration, didn't have a significant association with the development of any dementia, vascular dementia or Alzheimer's disease among male veterans with nonmetastatic prostate cancer who underwent definitive radiotherapy. The findings of the observational cohort study were published in JAMA Oncology.

Full Story: